Xiaoli Chen
Impact in
- Immunology top 10%
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immune Response and Inflammation
- Physiology top 5%
- Adenosine and Purinergic Signaling
Papers in
- Immunology 22
- Immune Response and Inflammation 8
- Immune cells in cancer 7
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 4
-
- Inflammasome and immune disorders 8
- Heme Oxygenase-1 and Carbon Monoxide 5
- Peroxisome Proliferator-Activated Receptors 4
- Co-authors
- Yuanfeng Zhu (12 shared papers)Xin Liu (8 shared papers)Shiyu Shu (3 shared papers)Jun Qin (3 shared papers)Zhihui Ma (2 shared papers)Yongling Lu (11 shared papers)Jiang Zheng (8 shared papers)Shijun Fan (11 shared papers)
- Journals
- Fish & Shellfish Immunology (5 papers)Frontiers in Immunology (2 papers)Redox Biology (2 papers)Blood (1 paper)Oncotarget (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xiaoli Chen
51 papers receiving 1.1k citations
Xiaoli Chen's Hit Papers
Peers
Comparison fields: 5 of 97
- Immunology 345
- Physiology 65
- Biological Psychiatry 23
- Neurology 71
- Molecular Biology 418
Countries citing papers authored by Xiaoli Chen
This map shows the geographic impact of Xiaoli Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Chen more than expected).
Fields of papers citing papers by Xiaoli Chen
This network shows the impact of papers produced by Xiaoli Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Chen. The network helps show where Xiaoli Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoli Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 142 | |
| 2 | 2022 | 124 | |
| 3 | Microglia activation in central nervous system disorders: A review of recent mechanistic investigations and development efforts Hit paper breakdown → | 2023 | 112 |
| 4 | 2017 | 42 | |
| 5 | 2003 | 38 | |
| 6 | 2021 | 36 | |
| 7 | 2022 | 35 | |
| 8 | 2024 | 31 | |
| 9 | 2022 | 30 | |
| 10 | 2018 | 28 | |
| 11 | 2014 | 27 | |
| 12 | 2023 | 26 | |
| 13 | 2008 | 26 | |
| 14 | 2016 | 25 | |
| 15 | 2022 | 24 | |
| 16 | 2016 | 24 | |
| 17 | 2007 | 22 | |
| 18 | 2021 | 20 | |
| 19 | 2019 | 19 | |
| 20 | 2003 | 19 |
About Xiaoli Chen
Xiaoli Chen is a scholar working on Immunology, Molecular Biology, Physiology, Epidemiology and Neurology, having authored 56 papers that have together received 1.1k indexed citations. Recurring topics across this work include Inflammasome and immune disorders (8 papers), Immune Response and Inflammation (8 papers), Immune cells in cancer (7 papers), Adenosine and Purinergic Signaling (7 papers), Heme Oxygenase-1 and Carbon Monoxide (5 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers), Peroxisome Proliferator-Activated Receptors (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). The work is most often cited by research in Immunology (345 citations), Physiology (65 citations), Biological Psychiatry (23 citations), Neurology (71 citations) and Molecular Biology (418 citations). Xiaoli Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yuanfeng Zhu, Xin Liu, Shiyu Shu, Jun Qin, Zhihui Ma, Yongling Lu, Jiang Zheng, Shijun Fan, Shuo Li and Xuyun Geng. Their work appears in journals such as Fish & Shellfish Immunology, Frontiers in Immunology, Redox Biology, Blood and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.